14-day Premium Trial Subscription Try For FreeTry Free
$0.0625
+0 (+0%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0511 $0.0700 Friday, 3rd May 2024 BLPH stock ended at $0.0625. During the day the stock fluctuated 0% from a day low at $0.0625 to a day high of $0.0625.
90 days $0.0470 $0.0700
52 weeks $0.0290 $11.15

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
Jan 19, 2022 $2.77 $2.77 $2.66 $2.73 46 400
Jan 18, 2022 $2.80 $2.84 $2.70 $2.79 41 700
Jan 14, 2022 $3.12 $3.12 $2.59 $2.81 284 400
Jan 13, 2022 $3.06 $3.16 $2.92 $2.93 48 700
Jan 12, 2022 $3.21 $3.22 $3.01 $3.07 50 700
Jan 11, 2022 $3.25 $3.30 $3.08 $3.13 126 000
Jan 10, 2022 $3.04 $3.40 $2.94 $3.24 120 400
Jan 07, 2022 $3.07 $3.20 $2.92 $3.09 86 500
Jan 06, 2022 $3.17 $3.26 $2.95 $2.96 88 500
Jan 05, 2022 $3.23 $3.27 $3.19 $3.21 85 700
Jan 04, 2022 $3.21 $3.30 $3.08 $3.23 239 382
Jan 03, 2022 $3.07 $3.25 $2.85 $3.21 259 154
Dec 31, 2021 $3.08 $3.24 $3.03 $3.10 124 133
Dec 30, 2021 $2.89 $3.31 $2.88 $3.10 315 213
Dec 29, 2021 $2.87 $3.00 $2.83 $2.93 245 585
Dec 28, 2021 $2.75 $2.90 $2.73 $2.86 353 133
Dec 27, 2021 $2.86 $2.87 $2.65 $2.80 247 029
Dec 23, 2021 $2.85 $3.16 $2.80 $2.96 608 573
Dec 22, 2021 $2.79 $3.67 $2.75 $2.85 3 116 021
Dec 21, 2021 $2.48 $2.88 $2.47 $2.86 964 708
Dec 20, 2021 $2.51 $2.65 $2.42 $2.60 1 590 948
Dec 17, 2021 $3.45 $3.72 $2.93 $3.19 45 621 002
Dec 16, 2021 $2.37 $2.46 $2.35 $2.37 15 817
Dec 15, 2021 $2.48 $2.48 $2.34 $2.36 55 002
Dec 14, 2021 $2.62 $2.62 $2.45 $2.48 20 108
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT